| Literature DB >> 35131297 |
Ping Cai1, Hui-Yun Chen1, Wei-Tao Tang1, Yu-Duan Hu2, Shang-Yi Chen2, Jing-Shan Lu3, Zhi-Hui Lin1, Sheng-Nan Huang1, Li-Huan Hu3, Wei-Kun Su3, Qi-Xuan Li4, Zhi-Jie Lin4, Tian-Rui Kang4, Xiong-Bin Yan4, Pei-Chang Liu5, Li Chen6, Dou Yin7, Si-Ying Wu2, Huang-Yuan Li8, Changxi Yu9.
Abstract
Defensive behavior, a group of responses that evolved due to threatening stimuli, is crucial for animal survival in the natural environment. For defensive measures to be timely and successful, a high arousal state and immediate sleep-to-wakefulness transition are required. Recently, the glutamatergic basal forebrain (BF) has been implicated in sleep-wake regulation; however, the associated physiological functions and underlying neural circuits remain unknown. Here, using in vivo fiber photometry, we found that BF glutamatergic neuron is activated by various threatening stimuli, including predator odor, looming threat, sound, and tail suspension. Optogenetic activation of BF glutamatergic neurons induced a series of context-dependent defensive behaviors in mice, including escape, fleeing, avoidance, and hiding. Similar to the effects of activated BF glutamatergic cell body, photoactivation of BF glutamatergic terminals in the ventral tegmental area (VTA) strongly drove defensive behaviors in mice. Using synchronous electroencephalogram (EEG)/electromyogram (EMG) recording, we showed that photoactivation of the glutamatergic BF-VTA pathway produced an immediate transition from sleep to wakefulness and significantly increased wakefulness. Collectively, our results clearly demonstrated that the glutamatergic BF is a key neural substrate involved in wakefulness and defensive behaviors, and encodes these behaviors through glutamatergic BF-VTA pathway. Overexcitation of the glutamatergic BF-VTA pathway may be implicated in clinical psychiatric diseases characterized by exaggerated defensive responses, such as autism spectrum disorders.Entities:
Keywords: Basal forebrain; Defensive behavior; Glutaminergic neurons; Sleep-wake behavior; Ventral tegmental area
Mesh:
Year: 2022 PMID: 35131297 DOI: 10.1016/j.neuropharm.2022.108979
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250